RxDoctor Payments Data

Michael Carozza, MD

Gynecology · Arkadelphia, ARNPI 1093772055

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.3% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations.

$1,977in general payments, 2019–2025

Across 93 payments — averaging $21.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$415
  • AbbVie$162
  • Medtronic$157
  • Organon$149
  • Daiichi Sankyo Inc.$133
  • Dexcom, Inc.$111
  • plus $851 from 19 others

What the payments were for

  • Food & beverage$1,96399%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,977 in reported general payments places this provider in the 80th percentile of 26 gynecology providers in Arkansas.

See all gynecology providers in Arkansas

Medicare billing

Part B allowed, 2024
$7,334
Medicare patients
13
Services billed
16

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol45$1,619
Tolterodine Tartrate ErTolterodine Tartrate22$1,519
DottiEstradiol11$688
Solifenacin Succinate15$484
Clobetasol Propionate11$278
Medroxyprogesterone Acetate11$32

Paid to pharmacies, not to this prescriber.

Other gynecology in Arkadelphia

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →